Evergraf 0.25mg Tablet
Marketer
Panacea Biotec Pharma Ltd
Salt Composition
Everolimus (0.25mg)
Overview Evergraf 0.25mg Tablet
Transgraf 0.25mg tablets prevent organ rejection in transplant recipients by modulating the immune system's response to facilitate organ acceptance. This medication also features in combination therapies for breast, pancreatic, lung, and kidney cancers. Dosage and duration of Transgraf 0.25mg tablets should strictly adhere to prescribed guidelines. Administration may coincide with or diverge from mealtimes, but consistency in daily timing is crucial. Overdosage poses significant health risks. Frequently reported side effects comprise infection, pyrexia, cough, lassitude, diarrhea, and upper respiratory tract infections. Persistent or troublesome side effects warrant immediate medical consultation. Allergic reactions (e.g., skin rashes, dyspnea, cough, edema) necessitate immediate physician notification. Seek medical guidance for excessive thirst or urination, respiratory distress, cough, fever, or vaccination needs during treatment. Prior to commencing Transgraf 0.25mg tablets, disclose all current medications and pre-existing conditions to your doctor. Pregnant or breastfeeding individuals must inform their physician before initiating treatment. Regular blood tests may be recommended to monitor the medication's impact. This medication might influence fertility in both sexes; consult your doctor regarding family planning.
Uses of Evergraf 0.25mg Tablet
Preventing organ transplant rejection
Major Benefits of Evergraf 0.25mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 0.25mg Evergraf tablet whole; avoid chewing, crushing, or breaking it. While Evergraf can be taken with or without food, consistent timing is recommended.
Common Side effects of Evergraf 0.25mg Tablet:
- Infection
- Fever
- Cough
- Fatigue
- Diarrhea
- Upper respiratory tract infection
How to use Evergraf 0.25mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Evergraf 0.25mg tablets can be consumed with or without food, although consistent daily timing is recommended.
How Evergraf 0.25mg Tablet works:
Evergraf 0.25mg tablets modulate the immune response, thereby reducing the risk of transplant rejection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Evergraf 0.25mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Evergraf 0.25mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Medical advice is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of Evergraf 0.25mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Evergraf 0.25mg Tablets, a potential side effect of which is fatigue. This fatigue is a common occurrence among users of Evergraf 0.25mg Tablets.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely take Evergraf 0.25mg tablets without requiring a dosage change.
LiverCAUTION
Patients with liver impairment should use Evergraf 0.25mg tablets cautiously, potentially requiring dose modification under medical supervision. Evergraf 0.25mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Evergraf 0.25mg Tablet :
NA
Facts to Know About Evergraf 0.25mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Macrolide Antibiotics |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently